Enhanced Expression of the Epstein–Barr Virus Latent Membrane Protein by a Recombinant Vaccinia Virus

References

1. Arrand J. R., Rymo L., Walsh J. E., Bjorck E., Lindahl T., Griffin B. E. 1981; Molecular cloning of the complete Epstein–Barr virus genome as a set of overlapping restriction endonuclease fragments. Nucleic Acids Research 9 2999 3014
   [Google Scholar]
2. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Seguin C., Tuffnell P. S., Barrell B. G. 1984; DNA sequence and expression of the B95-8 Epstein–Barr virus genome. Nature, London 310 207 211
   [Google Scholar]
3. Bankier A. T., Deininger P. L., Satchwell S. C., Baer R., Farrell P. J., Barrell B. G. 1983; DNA sequence analysis of the EcoRI Dhet fragment of B95-8 Epstein–Barr virus containing the terminal repeat sequences. Molecular Biology and Medicine 1 425 446
   [Google Scholar]
4. Ben-Bassat H., Goldblum N., Mitrani S., Goldblum T., Yoffey J. M., Cohen M. M., Bentwich Z., Ramot B., Klein E., Klein G. 1977; Establishment in continuous culture of a new type of lymphocyte from a ‘Burkitt-like’ malignant lymphoma (line DG-75). International Journal of Cancer 19 27 33
   [Google Scholar]
5. Borysiewicz L. K., Hickling J. K., Graham S., Sinclair J., Cranage M. P., Smith G. L., Sissons J. G. P. 1988; Human cytomegalovirus-specific cytotoxic T cells: relative frequency of stage specific CTL recognising the 72KDa immediate-early protein and glycoprotein B expressed by recombinant vaccinia viruses. Journal of Experimental Medicine 168 919 931
   [Google Scholar]
6. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., Macdonald S., Pulford K. A. F., Stein H., Mason D. Y. 1984; Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). Journal of Histochemistry and Cytochemistry 32 219 229
   [Google Scholar]
7. Crawford D. H., Epstein M. A., Bornkamm G. W., Achong B. G., Finerty S., Thompson I. L. 1979; Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas. International Journal of Cancer 24 294 302
   [Google Scholar]
8. Dambaugh T., Hennessy K., Fennewald S., Kieff E. 1986; The virus genome and its expression in latent infection. In The Epstein–Barr Virus: Recent Advances pp. 13 45 Edited by Epstein M. A., Achong B. G. London:: Heinemann;
   [Google Scholar]
9. Dillner J., Kallin B. 1988; The Epstein–Barr virus proteins. Advances in Cancer Research 50 95 158
   [Google Scholar]
10. Fennewald S., Van Santen V., Kieff E. 1984; Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. Journal of Virology 51 411 419
    [Google Scholar]
11. Gubler U., Hoffman B. J. 1983; A simple and very efficient method for generating cDNA libraries. Gene 25 263 269
    [Google Scholar]
12. Hatfull G., Bankier A. T., Barrell B. G., Farrell P. J. 1988; Sequence analysis of Raji Epstein–Barr virus DNA. Virology 164 334 340
    [Google Scholar]
13. Hatzubai R. A., Lerner R. A., Klein G., Sulitzeanu D. 1988; Proteins in normal and malignant cells cross reacting with the latent membrane protein encoded by Epstein–Barr virus. European Journal of Immunology 18 1283 1288
    [Google Scholar]
14. Hennessy K., Fennewald S., Hummel M., Cole T., Kieff E. 1984; A membrane protein encoded by Epstein–Barr virus in latent growth-transforming infection. Proceedings of the National Academy of Sciences U.S.A 81 7207 7211
    [Google Scholar]
15. Hiraki S., Miyoshi I., Masuji H., Kubonishi I., Matsuda Y., Nakayama T., Kishimoto H., Chen P., Kimura I. 1977; Establishment of an Epstein–Barr virus-determined nuclear antigen-negative human B-cell line from acute lymphoblastic leukemia. Journal of the National Cancer Institute 59 93 94
    [Google Scholar]
16. Hsu S-M., Soban E. 1982; Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double irnmunohistochemistry. Journal of Histochemistry and Cytochemistry 30 1079 1082
    [Google Scholar]
17. Hudson G. S., Farrell P. J., Barrell B. G. 1985; Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein–Barr virus B95-8. Journal of Virology 53 528 535
    [Google Scholar]
18. Laux G., Perricaudet M., Farrell P. J. 1988; A spliced Epstein–Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. EMBO Journal 7 769 774
    [Google Scholar]
19. Leon J., Kamino H., Steinberg I. J., Pellicer A. 1988; H-ras activation in benign and self-regressing skin tumors (keratoacanthomas) in both humans and an animal model system. Molecular and Cellular Biology 8 786 793
    [Google Scholar]
20. Liebowitz D., Wang D., Kieff E. 1986; Orientation and patching of the latent infection membrane protein encoded by Epstein–Barr virus. Journal of Virology 58 233 237
    [Google Scholar]
21. Liebowitz D., Kopan R., Fuchs E., Sample J., Kieff E. 1987; An Epstein–Barr virus transforming protein associates with vimentin in lymphocytes. Molecular and Cellular Biology 7 2299 2308
    [Google Scholar]
22. Mackett M., Arrand J. R. 1985; Recombinant vaccinia virus induces neutralizing antibodies in rabbits against Epstein–Barr virus membrane antigen gp340. EMBO Journal 4 3229 3243
    [Google Scholar]
23. Mackett M., Smith G. L., Moss B. 1985; The construction and characterization of vaccinia virus recombinants expressing foreign genes. In DNA Cloning: A Practical Approach vol. 2 pp. 191 211 Edited by Glover D. Oxford:: IRL Press;
    [Google Scholar]
24. Mann K. P., Thorley-Lawson D. 1987; Post-translational processing of the Epstein–Barr virus-encoded p63/LMP protein. Journal of Virology 61 2100 2108
    [Google Scholar]
25. Mann K. P., Staunton D., Thorley-Lawson D. A. 1985; Epstein–Barr virus encoded protein found in plasma membranes of transformed cells. Journal of Virology 55 710 720
    [Google Scholar]
26. Matlashewski G. J., Tuck S., Pim D., Lamb P., Schneider J., Crawford L. V. 1987; Primary structure polymorphism at amino acid residue 72 of human p53. Molecular and Cellular Biology 7 961 963
    [Google Scholar]
27. Modrow S., Wolf H. 1986; Characterization of two related Epstein–Barr virus-encoded membrane proteins that are differentially expressed in Burkitt lymphoma and in vitro-transformed cell lines. Proceedings of the National Academy of Sciences U.S.A 83 5703 5707
    [Google Scholar]
28. Murray R. I., Wang D., Young L. S., Wang F., Rowe M., Kieff E., Rickinson A. B. 1988a; Epstein–Barr virus cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP. Journal of Virology 62 3747 3755
    [Google Scholar]
29. Murray R. J., Young L. S., Calendar A., Gregory C. D., Rowe M., Lenoir G. M., Rickinson A. B. 1988b; Different patterns of Epstein–Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95-8) or nontransforming (P3HR1) virus strains. Journal of Virology 62 894 901
    [Google Scholar]
30. Rhim J. S., Cho H. Y., Huebner R. J. 1975; Non-producer human cells induced by murine sarcoma virus. International Journal of Cancer 15 23 29
    [Google Scholar]
31. Rowe D. T., Rowe M., Evan G. I., Wallace L. E., Farrell P. J., Rickinson A. B. 1986; Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt’s lymphoma cells. EMBO Journal 5 2599 2607
    [Google Scholar]
32. Rowe M., Evans H. S., Young L. S., Hennessy K., Kieff E., Rickinson A. B. 1987; Monoclonal antibodies to the latent membrane protein of Epstein–Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. Journal of General Virology 68 1575 1586
    [Google Scholar]
33. Rowe M., Finke J., Szigeti R., Klein G. 1988; Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein–Barr virus. Journal of General Virology 69 1217 1228
    [Google Scholar]
34. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences U.S.A 74 5463 5467
    [Google Scholar]
35. Thorley-Lawson D. A., Israelsohn E. S. 1987; Generation of specific cytotoxic T cells with a fragment of the Epstein–Barr virus-encoded p63/latent membrane protein. Proceedings of the National Academy of Sciences U.S.A 84 5384 5388
    [Google Scholar]
36. Tugwood J. D., Lau W-H., O S-K., Tsao S-T., Martin W. M. C., Shiu W., Desgranges C, Jones P. H., Arrand J. R. 1987; Epstein–Barr virus-specific transcription in normal and malignant nasopharyngeal biopsies and in lymphocytes from healthy donors and infectious mononucleosis patients. Journal of General Virology 68 1081 1091
    [Google Scholar]
37. Wang D., Liebowitz D., Kieff E. 1985; An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43 831 840
    [Google Scholar]
38. Wang D., Liebowitz D., Kieff E. 1988; The truncated form of the Epstein–Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts. Journal of Virology 62 2337 2346
    [Google Scholar]
39. Yilma T., Ristow S. S., Moss B., Jones L. 1987; A novel approach for the production of monoclonal antibodies using infectious vaccinia virus recombinants. Hybridoma 6 329 335
    [Google Scholar]
40. Young L. S., Dawson C. W., Clark D., Rupani H., Busson P., Tursz T., Johnson A., Rickinson A. B. 1988; Epstein–Barr virus gene expression in nasopharyngeal carcinoma. Journal of General Virology 69 1051 1065
    [Google Scholar]